Skip to search formSkip to main contentSkip to account menu

TNFRSF10D gene

Known as: TRAIL RECEPTOR WITH A TRUNCATED DEATH DOMAIN, DECOY RECEPTOR 2, TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 10D 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2014
Highly Cited
2014
Background: The mechanisms through which TRAILR4 interferes with proapoptotic signaling are not conclusively elucidated. Results… 
Highly Cited
2010
Highly Cited
2010
Discovery of the molecular targets of traditional medicine and its chemical footprints can validate the use of such medicine. In… 
Highly Cited
2007
Highly Cited
2007
Promoter CpG island hypermethylation is an important carcinogenic event in prostate adenocarcinoma. Regardless of tissue type… 
Highly Cited
2006
Highly Cited
2006
Prostate carcinoma is a hormonally driven age-related neoplasm. Cellular senescence is an age-related process where cells remain… 
Highly Cited
2005
Highly Cited
2005
Decoy receptor 2 (DcR2) is one of the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) receptors and suppresses… 
Highly Cited
2002
Highly Cited
2002
TRAIL (tumor necrosis factor-related apoptosis-inducing ligand) induces apoptosis in a large variety of cancer cells but not in… 
Highly Cited
2000
Highly Cited
2000
The cell surface decoy receptor proteins TRID (also known as DcR1 or TRAIL-R3) and TRUNDD (DcR2, TRAIL-R4) inhibit caspase…